Journal
ONCOLOGY LETTERS
Volume 15, Issue 4, Pages 5339-5344Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2018.7970
Keywords
estrogen receptor-alpha; splice variant; biological behaviours; breast cancer; MDA-MB-231 cells
Categories
Funding
- Guangxi Provincial Natural Science Foundation of China [2013GXNSFBA019189]
Ask authors/readers for more resources
Since the early 1990s, multiple human estrogen receptor-alpha (hER-alpha) splice variants have been identified, of which the majority contain >= 1 deleted exon, and some are expressed as proteins with modified functions from the wild-type 66 kD alpha hER-alpha (ER-alpha 66). In the present study, a novel hER-alpha splice variant, ER-alpha 30, was identified and cloned from clinical breast cancer tissue. The ER-alpha 30 sequence lacked a ligand-binding domain and a ligand-dependent transcriptional activation domain but retained the N-terminal transcriptional activation domain, the DNA-binding domain and a partial hinge domain, and possesses a unique 10-amino-acid domain. The expression of ER-alpha 30 was associated with ER-alpha 66-negative and progesterone receptor-negative breast cancer. The 30 kDa protein was expressed in stably transfected MDA-MB-231 cells, and the overexpression of ER-alpha 30 in MDA-MB-231 cells enhanced malignant biological behaviors, including cellular proliferation, migration and invasion in vitro. The results of the present study indicated that ER-alpha 30 might represent a potential biomarker for breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available